Trial
NCT01280669
Intravitreal Sirolimus as Therapeutic Approach to Uveitis
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
Santen Inc.
Condition
Uveitis
Intervention
Intravitreal injection 440mcg
Why stopped
Never started due to sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-26